首页 › 基金 › ALETHEA CAPITAL MANAGEMENT, LLC › AXSM
ALETHEA CAPITAL MANAGEMENT, LLC 对 AXSM 的持仓历史
AXSOME THERAPEUTICS INC. · 医疗保健
ALETHEA CAPITAL MANAGEMENT, LLC 在 Q3 2026 的 13F 申报中披露持有 AXSM(AXSOME THERAPEUTICS INC.)649,117 股,市值约 US$119.7M,约占其申报组合的 60.89%,在其申报持仓中市值排名第 1 位。 ALETHEA CAPITAL MANAGEMENT, LLC 最近 13 个申报季度中有 13 个季度披露了 AXSM 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
ALETHEA CAPITAL MANAGEMENT, LLC 对 AXSM 的持仓演变
ALETHEA CAPITAL MANAGEMENT, LLC 于 Q3 2023 首次披露 AXSM 持仓:758,794 股(约 US$53.0M)。 该持仓在 Q2 2026 达到峰值 648,756 股,市值约 US$158.8M。 在 13 次申报中,ALETHEA CAPITAL MANAGEMENT, LLC 1 次增持、5 次减持、6 次保持不变。 最近一期申报(Q3 2026)显示持股 649,117 股、市值约 US$119.7M。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 758.79K | $53.03M | 新进 |
| Q4 2023 | 752.04K | $59.86M | 减持 |
| Q1 2024 | 740.79K | $59.12M | 减持 |
| Q2 2024 | 740.89K | $59.64M | 持有 |
| Q3 2024 | 738.50K | $66.37M | 持有 |
| Q4 2024 | 734.32K | $62.13M | 减持 |
| Q1 2025 | 667.37K | $77.84M | 减持 |
| Q2 2025 | 667.37K | $69.67M | 持有 |
| Q3 2025 | 670.88K | $81.48M | 增持 |
| Q4 2025 | 668.71K | $122.13M | 持有 |
| Q1 2026 | 649.11K | $109.71M | 减持 |
| Q2 2026 | 648.76K | $158.80M | 持有 |
| Q3 2026 | 649.12K | $119.69M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 AXSM 与 13F 数据
AXSM(AXSOME THERAPEUTICS INC.)属于医疗保健行业。我们追踪的基金中还有 49 只申报持有 AXSM,申报仓位最大的包括:Deep Track Capital, LP (US$171.3M), Hood River Capital Management LLC (US$98.6M), EVENTIDE ASSET MANAGEMENT, LLC (US$77.5M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 AXSM 的基金
- Deep Track Capital, LP 700.00K 股 · $171.34M · Q2 2026
- Hood River Capital Management LLC 402.68K 股 · $98.56M · Q2 2026
- EVENTIDE ASSET MANAGEMENT, LLC 316.82K 股 · $77.53M · Q2 2026
- Integral Health Asset Management, LLC 300.00K 股 · $73.43M · Q2 2026
- FRONTIER CAPITAL MANAGEMENT CO LLC 254.28K 股 · $62.24M · Q2 2026
- SAMLYN CAPITAL, LLC 246.01K 股 · $60.22M · Q2 2026
- PFM Health Sciences, LP 219.60K 股 · $53.75M · Q2 2026
- Tri Locum Partners LP 219.31K 股 · $53.68M · Q2 2026
- First Turn Management, LLC 218.41K 股 · $53.46M · Q2 2026
- Cannell & Spears LLC 259.65K 股 · $47.88M · Q3 2026
更多关于 ALETHEA CAPITAL MANAGEMENT, LLC
常见问题
How long has ALETHEA CAPITAL MANAGEMENT, LLC held AXSM?
ALETHEA CAPITAL MANAGEMENT, LLC has disclosed AXSM holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is ALETHEA CAPITAL MANAGEMENT, LLC's current position in AXSM?
As of Q3 2026, ALETHEA CAPITAL MANAGEMENT, LLC holds 649.12K shares of AXSM (AXSOME THERAPEUTICS INC.), valued at $119.69M, representing 60.89% of its reported portfolio and ranking #1.
Has ALETHEA CAPITAL MANAGEMENT, LLC been buying or selling AXSM?
In the latest 13F filing (Q3 2026), ALETHEA CAPITAL MANAGEMENT, LLC held unchanged its position in AXSM. The position peaked in Q2 2026 at 648.76K shares.
Which other funds hold AXSM?
Other major institutional holders of AXSM include Deep Track Capital, LP, Hood River Capital Management LLC, EVENTIDE ASSET MANAGEMENT, LLC, among 49 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.